Does ALPELISIB Cause Psychiatric decompensation? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Psychiatric decompensation have been filed in association with ALPELISIB (PIQRAY). This represents 0.1% of all adverse event reports for ALPELISIB.
11
Reports of Psychiatric decompensation with ALPELISIB
0.1%
of all ALPELISIB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Psychiatric decompensation From ALPELISIB?
Of the 11 reports, 10 (90.9%) required hospitalization, and 10 (90.9%) were considered life-threatening.
Is Psychiatric decompensation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALPELISIB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does ALPELISIB Cause?
Hyperglycaemia (1,575)
Rash (1,393)
Diarrhoea (1,336)
Blood glucose increased (1,105)
Death (921)
Nausea (860)
Fatigue (817)
Decreased appetite (546)
Weight decreased (508)
Malignant neoplasm progression (497)
What Other Drugs Cause Psychiatric decompensation?
CLOZAPINE (368)
ARIPIPRAZOLE (291)
QUETIAPINE (212)
RISPERIDONE (176)
BUPROPION (152)
OLANZAPINE (135)
RALTEGRAVIR (132)
EFAVIRENZ (131)
CLONAZEPAM (128)
ATAZANAVIR (123)
Which ALPELISIB Alternatives Have Lower Psychiatric decompensation Risk?
ALPELISIB vs ALPHA.-LIPOIC ACID
ALPELISIB vs ALPHA.-TOCOPHEROL
ALPELISIB vs ALPHA.-TOCOPHEROL, D-
ALPELISIB vs ALPHA.-TOCOPHEROL, DL-
ALPELISIB vs ALPHA.1-PROTEINASE INHIBITOR HUMAN